Literature DB >> 33498226

Sequence Comparison of Vaginolysin from Different Gardnerella Species.

Erin M Garcia1, Myrna G Serrano1,2, Laahirie Edupuganti1,2, David J Edwards2,3, Gregory A Buck1,2,4, Kimberly K Jefferson1,2.   

Abstract

Gardnerella vaginalis has recently been split into 13 distinct species. In this study, we tested the hypotheses that species-specific variations in the vaginolysin (VLY) amino acid sequence could influence the interaction between the toxin and vaginal epithelial cells and that VLY variation may be one factor that distinguishes less virulent or commensal strains from more virulent strains. This was assessed by bioinformatic analyses of publicly available Gardnerella spp. sequences and quantification of cytotoxicity and cytokine production from purified, recombinantly produced versions of VLY. After identifying conserved differences that could distinguish distinct VLY types, we analyzed metagenomic data from a cohort of female subjects from the Vaginal Human Microbiome Project to investigate whether these different VLY types exhibited any significant associations with symptoms or Gardnerella spp.-relative abundance in vaginal swab samples. While Type 1 VLY was most prevalent among the subjects and may be associated with increased reports of symptoms, subjects with Type 2 VLY dominant profiles exhibited increased relative Gardnerella spp. abundance. Our findings suggest that amino acid differences alter the interaction of VLY with vaginal keratinocytes, which may potentiate differences in bacterial vaginosis (BV) immunopathology in vivo.

Entities:  

Keywords:  Gardnerella; bacterial vaginosis; vaginal microbiota; vaginolysin; virulence factors

Year:  2021        PMID: 33498226      PMCID: PMC7909246          DOI: 10.3390/pathogens10020086

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  39 in total

1.  Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis.

Authors:  David N Fredricks; Tina L Fiedler; Katherine K Thomas; Brian B Oakley; Jeanne M Marrazzo
Journal:  J Clin Microbiol       Date:  2007-08-08       Impact factor: 5.948

2.  Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars.

Authors:  Azad Ahmed; Josh Earl; Adam Retchless; Sharon L Hillier; Lorna K Rabe; Thomas L Cherpes; Evan Powell; Benjamin Janto; Rory Eutsey; N Luisa Hiller; Robert Boissy; Margaret E Dahlgren; Barry G Hall; J William Costerton; J Christopher Post; Fen Z Hu; Garth D Ehrlich
Journal:  J Bacteriol       Date:  2012-05-18       Impact factor: 3.490

3.  Interaction of Gardnerella vaginalis and Vaginolysin with the Apical versus Basolateral Face of a Three-Dimensional Model of Vaginal Epithelium.

Authors:  Erin M Garcia; Vita Kraskauskiene; Jennifer E Koblinski; Kimberly K Jefferson
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

4.  Specific immune response against Gardnerella vaginalis hemolysin in patients with bacterial vaginosis.

Authors:  S Cauci; F Scrimin; S Driussi; S Ceccone; R Monte; L Fant; F Quadrifoglio
Journal:  Am J Obstet Gynecol       Date:  1996-12       Impact factor: 8.661

5.  Correlation of local interleukin-1beta levels with specific IgA response against Gardnerella vaginalis cytolysin in women with bacterial vaginosis.

Authors:  Sabina Cauci; Silvia Driussi; Secondo Guaschino; Miriam Isola; Franco Quadrifoglio
Journal:  Am J Reprod Immunol       Date:  2002-05       Impact factor: 3.886

6.  Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential.

Authors:  Carl J Yeoman; Suleyman Yildirim; Susan M Thomas; A Scott Durkin; Manolito Torralba; Granger Sutton; Christian J Buhay; Yan Ding; Shannon P Dugan-Rocha; Donna M Muzny; Xiang Qin; Richard A Gibbs; Steven R Leigh; Rebecca Stumpf; Bryan A White; Sarah K Highlander; Karen E Nelson; Brenda A Wilson
Journal:  PLoS One       Date:  2010-08-26       Impact factor: 3.240

7.  Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.

Authors:  Joana Castro; Patrícia Alves; Cármen Sousa; Tatiana Cereija; Ângela França; Kimberly K Jefferson; Nuno Cerca
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

8.  Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis.

Authors:  Migle Janulaitiene; Virginija Paliulyte; Svitrigaile Grinceviciene; Jolita Zakareviciene; Alma Vladisauskiene; Agne Marcinkute; Milda Pleckaityte
Journal:  BMC Infect Dis       Date:  2017-06-05       Impact factor: 3.090

9.  All major cholesterol-dependent cytolysins use glycans as cellular receptors.

Authors:  Lucy K Shewell; Christopher J Day; Freda E-C Jen; Thomas Haselhorst; John M Atack; Josephine F Reijneveld; Arun Everest-Dass; David B A James; Kristina M Boguslawski; Stephan Brouwer; Christine M Gillen; Zhenyao Luo; Bostjan Kobe; Victor Nizet; Mark von Itzstein; Mark J Walker; Adrienne W Paton; James C Paton; Victor J Torres; Michael P Jennings
Journal:  Sci Adv       Date:  2020-05-22       Impact factor: 14.136

10.  MUSCLE: a multiple sequence alignment method with reduced time and space complexity.

Authors:  Robert C Edgar
Journal:  BMC Bioinformatics       Date:  2004-08-19       Impact factor: 3.169

View more
  3 in total

1.  Nuclear Magnetic Resonance Metabolomics of Symbioses between Bacterial Vaginosis-Associated Bacteria.

Authors:  Victoria Horrocks; Charlotte K Hind; Matthew E Wand; Paul-Enguerrand Fady; Joel Chan; Jade C Hopkins; Georgina L Houston; Rachel M Tribe; J Mark Sutton; A James Mason
Journal:  mSphere       Date:  2022-05-02       Impact factor: 5.029

2.  Tilapia Piscidin 4 (TP4) Reprograms M1 Macrophages to M2 Phenotypes in Cell Models of Gardnerella vaginalis-Induced Vaginosis.

Authors:  Chia-Wen Liu; Bor-Chyuan Su; Jyh-Yih Chen
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

3.  Association of key species of vaginal bacteria of recurrent bacterial vaginosis patients before and after oral metronidazole therapy with short- and long-term clinical outcomes.

Authors:  Ashomathi Mollin; Mounika Katta; Jack D Sobel; Robert A Akins
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.